Gene Expression and Targeted Therapies— New Developments in Melanoma Treatment
Michael P O’Connell, Ashani T Weeraratna
Between 1973 and 1998, the incidence and mortality of melanoma in the US increased at rates higher than those for most other preventable cancers.1 In 2007 alone, there were an estimated 59,940 cases of melanoma diagnosed and 8,110 reported mortalities.2 Therapeutic approaches currently undertaken include cancer-specific vaccines, chemotherapy, biochemotherapy, cytokines, specific immunostimulants, and monoclonal antibodies.3 […]